Cargando…

Body Mass Index and Breast Cancer Defined by Biological Receptor Status in Pre-Menopausal and Post-Menopausal Women: A Multicenter Study in China

BACKGROUND: Few studies have investigated the association between body mass index (BMI) and breast cancer with consideration to estrogen/progesterone/human epidermal growth factor type 2 receptor status (ER/PR/HER2) in the breast tissue among Chinese pre- and post-menopausal women. METHODS: Four tho...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jing, Huang, Yuan, Zhang, Bao-Ning, Fan, Jin-Hu, Huang, Rong, Zhang, Pin, Wang, Shu-Lian, Zheng, Shan, Zhang, Bin, Yang, Hong-Jian, Xie, Xiao-Ming, Tang, Zhong-Hua, Li, Hui, He, Jian-Jun, Hsieh, Evelyn, Qiao, You-Lin, Li, Jia-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906138/
https://www.ncbi.nlm.nih.gov/pubmed/24489874
http://dx.doi.org/10.1371/journal.pone.0087224
_version_ 1782301446297878528
author Li, Jing
Huang, Yuan
Zhang, Bao-Ning
Fan, Jin-Hu
Huang, Rong
Zhang, Pin
Wang, Shu-Lian
Zheng, Shan
Zhang, Bin
Yang, Hong-Jian
Xie, Xiao-Ming
Tang, Zhong-Hua
Li, Hui
He, Jian-Jun
Hsieh, Evelyn
Qiao, You-Lin
Li, Jia-Yuan
author_facet Li, Jing
Huang, Yuan
Zhang, Bao-Ning
Fan, Jin-Hu
Huang, Rong
Zhang, Pin
Wang, Shu-Lian
Zheng, Shan
Zhang, Bin
Yang, Hong-Jian
Xie, Xiao-Ming
Tang, Zhong-Hua
Li, Hui
He, Jian-Jun
Hsieh, Evelyn
Qiao, You-Lin
Li, Jia-Yuan
author_sort Li, Jing
collection PubMed
description BACKGROUND: Few studies have investigated the association between body mass index (BMI) and breast cancer with consideration to estrogen/progesterone/human epidermal growth factor type 2 receptor status (ER/PR/HER2) in the breast tissue among Chinese pre- and post-menopausal women. METHODS: Four thousand two hundred and eleven breast cancer patients were selected randomly from seven geographic regions of China from 1999 to 2008. Demographic data, risk factors, pathologic features, and biological receptor status of cases were collected from the medical charts. Chi-square test, fisher exact test, rank-correlation analysis, and multivariate logistic regression model were adopted to explore whether BMI differed according to biological receptor status in pre- and post-menopausal women. RESULTS: Three thousand two hundred and eighty one eligible cases with BMI data were included. No statistically significant differences in demographic characteristics were found between the cases with BMI data and those without. In the rank-correlation analysis, the rates of PR+ and HER2+ were positively correlated with increasing BMI among post-menopausal women (r(s BMI, PR+) = 0.867, P = 0.001; r(s BMI, HER2+) = 0.636, P = 0.048), but the ER+ rates did not vary by increasing BMI. Controlling for confounding factors, multivariate logistic regression models with BMI<24 kg/m(2) as the reference group were performed and found that BMI≥24 kg/m(2) was only positively correlated with PR+ status among post-menopausal breast cancer cases (adjusted OR = 1.420, 95% CI: 1.116–1.808, Wald = 8.116, P = 0.004). CONCLUSIONS: Post-menopausal women with high BMI (≥24 kg/m(2)) have a higher proportion of PR+ breast cancer. In addition to effects mediated via the estrogen metabolism pathway, high BMI might increase the risk of breast cancer by other routes, which should be examined further in future etiological mechanism studies.
format Online
Article
Text
id pubmed-3906138
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-39061382014-01-31 Body Mass Index and Breast Cancer Defined by Biological Receptor Status in Pre-Menopausal and Post-Menopausal Women: A Multicenter Study in China Li, Jing Huang, Yuan Zhang, Bao-Ning Fan, Jin-Hu Huang, Rong Zhang, Pin Wang, Shu-Lian Zheng, Shan Zhang, Bin Yang, Hong-Jian Xie, Xiao-Ming Tang, Zhong-Hua Li, Hui He, Jian-Jun Hsieh, Evelyn Qiao, You-Lin Li, Jia-Yuan PLoS One Research Article BACKGROUND: Few studies have investigated the association between body mass index (BMI) and breast cancer with consideration to estrogen/progesterone/human epidermal growth factor type 2 receptor status (ER/PR/HER2) in the breast tissue among Chinese pre- and post-menopausal women. METHODS: Four thousand two hundred and eleven breast cancer patients were selected randomly from seven geographic regions of China from 1999 to 2008. Demographic data, risk factors, pathologic features, and biological receptor status of cases were collected from the medical charts. Chi-square test, fisher exact test, rank-correlation analysis, and multivariate logistic regression model were adopted to explore whether BMI differed according to biological receptor status in pre- and post-menopausal women. RESULTS: Three thousand two hundred and eighty one eligible cases with BMI data were included. No statistically significant differences in demographic characteristics were found between the cases with BMI data and those without. In the rank-correlation analysis, the rates of PR+ and HER2+ were positively correlated with increasing BMI among post-menopausal women (r(s BMI, PR+) = 0.867, P = 0.001; r(s BMI, HER2+) = 0.636, P = 0.048), but the ER+ rates did not vary by increasing BMI. Controlling for confounding factors, multivariate logistic regression models with BMI<24 kg/m(2) as the reference group were performed and found that BMI≥24 kg/m(2) was only positively correlated with PR+ status among post-menopausal breast cancer cases (adjusted OR = 1.420, 95% CI: 1.116–1.808, Wald = 8.116, P = 0.004). CONCLUSIONS: Post-menopausal women with high BMI (≥24 kg/m(2)) have a higher proportion of PR+ breast cancer. In addition to effects mediated via the estrogen metabolism pathway, high BMI might increase the risk of breast cancer by other routes, which should be examined further in future etiological mechanism studies. Public Library of Science 2014-01-29 /pmc/articles/PMC3906138/ /pubmed/24489874 http://dx.doi.org/10.1371/journal.pone.0087224 Text en © 2014 Li et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Li, Jing
Huang, Yuan
Zhang, Bao-Ning
Fan, Jin-Hu
Huang, Rong
Zhang, Pin
Wang, Shu-Lian
Zheng, Shan
Zhang, Bin
Yang, Hong-Jian
Xie, Xiao-Ming
Tang, Zhong-Hua
Li, Hui
He, Jian-Jun
Hsieh, Evelyn
Qiao, You-Lin
Li, Jia-Yuan
Body Mass Index and Breast Cancer Defined by Biological Receptor Status in Pre-Menopausal and Post-Menopausal Women: A Multicenter Study in China
title Body Mass Index and Breast Cancer Defined by Biological Receptor Status in Pre-Menopausal and Post-Menopausal Women: A Multicenter Study in China
title_full Body Mass Index and Breast Cancer Defined by Biological Receptor Status in Pre-Menopausal and Post-Menopausal Women: A Multicenter Study in China
title_fullStr Body Mass Index and Breast Cancer Defined by Biological Receptor Status in Pre-Menopausal and Post-Menopausal Women: A Multicenter Study in China
title_full_unstemmed Body Mass Index and Breast Cancer Defined by Biological Receptor Status in Pre-Menopausal and Post-Menopausal Women: A Multicenter Study in China
title_short Body Mass Index and Breast Cancer Defined by Biological Receptor Status in Pre-Menopausal and Post-Menopausal Women: A Multicenter Study in China
title_sort body mass index and breast cancer defined by biological receptor status in pre-menopausal and post-menopausal women: a multicenter study in china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906138/
https://www.ncbi.nlm.nih.gov/pubmed/24489874
http://dx.doi.org/10.1371/journal.pone.0087224
work_keys_str_mv AT lijing bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina
AT huangyuan bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina
AT zhangbaoning bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina
AT fanjinhu bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina
AT huangrong bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina
AT zhangpin bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina
AT wangshulian bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina
AT zhengshan bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina
AT zhangbin bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina
AT yanghongjian bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina
AT xiexiaoming bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina
AT tangzhonghua bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina
AT lihui bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina
AT hejianjun bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina
AT hsiehevelyn bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina
AT qiaoyoulin bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina
AT lijiayuan bodymassindexandbreastcancerdefinedbybiologicalreceptorstatusinpremenopausalandpostmenopausalwomenamulticenterstudyinchina